PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Lynx1 Capital Management LP's Holding History (CIK: 0001910456)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 700,014 Value ($000) $46,502 Avg Close $56.84 Range $49.38 - $68.26

Q2 2025

Shares 733,014 Value ($000) $40,514 Avg Close $47.99 Range $39.60 - $57.70

Q1 2025

Shares 733,014 Value ($000) $35,449 Avg Close $41.90 Range $33.70 - $60.60

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	700,014	$46,502	$56.84	$49.38 - $68.26
Q2 2025	733,014	$40,514	$47.99	$39.60 - $57.70
Q1 2025	733,014	$35,449	$41.90	$33.70 - $60.60